The collection of plasma against the Covid-19 stopped in metropolis, trial underway in French Guiana

“We have enough plasma from convalescent donors to meet the needs of this study,” the Etablissement français du sang said. A new step. Establishment f

“We have enough plasma from convalescent donors to meet the needs of this study,” the Etablissement français du sang said.

A new step. The Etablissement français du sang (EFS) has suspended the collection of plasma from patients cured of Covid-19, it said on Monday, explaining that it has “sufficient” inventory for the needs of a clinical trial of this treatment carried out by the French.

The researcher who conducted the study, Karine Lacombe, mentioned those sample verdicts during a hearing in the national assembly on Thursday, adding that the patients to be included in the trial, Mayotte and French Guiana, where the coronavirus is still actively circulating. “EFS no longer collects plasma donations in the context of the Coviplasm clinical trial because we have enough plasma from convalescent donors to meet the needs of this study,” the institution said.

READ ALSO >> Coronavirus: use of plasma from cured patients approved in France

Your support is essential. Subscribe for $1 help us

It also provides for the formation of a complementary “reserve” “for the care needs of patients in the event of demonstration of the efficacy of plasma transfusion and reversal of the epidemic, when it is time to return to the collection.”

Launched on April 7 by the EFS, the public aid hospitals of Paris (AP-HP) and the national institute for health and medical research (Inserm), this test consists of injecting Covid-19 patients with plasma containing antibodies against the sars coronavirus, to assess whether it helps fight the disease.

About 200 cured patients had to be taken in Île-de-France, in the largest and in Burgundy, Franche-Comté, while the trial had to include 120 patients in the acute phase of Covid-19: 60 who received plasma and 60 in the placebo group. But that figure has not yet been reached, explained Karine Lacombe in front of the representatives. “When we opened this text, at the beginning of April, we were already in the slowdown phase of the epidemic, with a rapid drop in the number of patients in the hospital.

“No preliminary conclusions”

In addition, many patients who arrived at the hospital at that time did not meet the “inclusion criteria in favor of the test plasma”, emphasized the head of the department of infectious diseases at the Saint-Antoine Hospital (AP-HP). “So at the moment we do not have preliminary results as we expected at the end of April or the beginning of May,” he added when asked by the members of the investigative commission on the management of the crisis caused by the Sars coronavirus.

The nine hospitals in Ile-de-France, which could include patients in the study, will add two centers, Mayotte and “Cayenne, in French Guiana, where the epidemic is seen to be at its peak, and the peak of the epidemic is not likely to be reached before the end of July,” announced Pr Lacombe.

Voices against this test are already being heard in Guyana. Jean-Victor Castor, Movement for Decolonization and Social Emancipation (MDES), on Facebook condemns the “scandal and criminal act”, calling for “general mobilization”, that “there is not a single proof in the head”. GDR MP Gabriel Serville, for his part, criticized the Regional Health Agency on Twitter, which he “hopes to turn patients into guinea pigs”.

Read our full file

Covid-19: 30 new deaths in France, 29,843 deaths since outbreak began, Prisoner transfer: Covid-19 cases explode in California prison Virus: US could reach 100,000 new cases a day, without intervention

In a letter to Health Minister Olivier Véran, LREM Senator Antoine Karam believes that “advanced concerns about the epidemic (…) cannot make Guyana a playing field where Hexagon researchers, however brilliant, want to continue their work.” He states that “the installation of such a center would be subject to discussion with the elected Guyanese to jointly assess its benefits, risks and limitations.”

Date updated: July 1, 2020, 00:58

Categories: Optical Illusion
Source: newstars.edu.vn

Leave a Comment